Your Blood Vessels Work Better High blood pressure often damages the inner lining of your blood vessels
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
Common reasons include concerns about side effects, cost, medication access, and a preference for gradual changes
Rybelsus, a semaglutide pill approved in 2019, has been used to treat type 2 diabetes
Eng C, Kramer CK, Zinman B, Retnakaran R
Gorach NV